 Connection
Behjatolah Karbassi to Antigens, Neoplasm
This is a "connection" page, showing publications Behjatolah Karbassi has written about Antigens, Neoplasm.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.427 |
|
|
|
-
Monzavi-Karbassi B, Cunto-Amesty G, Luo P, Lees A, Kieber-Emmons T. Immunological characterization of peptide mimetics of carbohydrate antigens in vaccine design strategies. Biologicals. 2001 Sep-Dec; 29(3-4):249-57.
Score: 0.182
-
Pashov A, Monzavi-Karbassi B, Chow M, Cannon M, Kieber-Emmons T. Immune surveillance as a rationale for immunotherapy? Hum Vaccin. 2007 Sep-Oct; 3(5):224-8.
Score: 0.068
-
Monzavi-Karbassi B, Hennings LJ, Artaud C, Liu T, Jousheghany F, Pashov A, Murali R, Hutchins LF, Kieber-Emmons T. Preclinical studies of carbohydrate mimetic peptide vaccines for breast cancer and melanoma. Vaccine. 2007 Apr 20; 25(16):3022-31.
Score: 0.066
-
Whitehead TL, Monzavi-Karbassi B, Jousheghany F, Artaud C, Elbein A, Kieber-Emmons T. 1H-NMR metabolic markers of malignancy correlate with spontaneous metastases in a murine mammary tumor model. Int J Oncol. 2005 Jul; 27(1):257-63.
Score: 0.059
-
Cunto-Amesty G, Monzavi-Karbassi B, Luo P, Jousheghany F, Kieber-Emmons T. Strategies in cancer vaccines development. Int J Parasitol. 2003 May; 33(5-6):597-613.
Score: 0.051
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|